Q
QIAGEN N.V.
QGENCIK 0001015820NYSELarge AcceleratedBiological Products, (No Diagnostic Substances)P7NLFY ends Dec 31
Period
FY 2025
Revenue
$2.09B
Net Income
$424.88M
Total Assets
$6.28B
Equity
$3.78B
Shares Out
216.92M
Op. Cash Flow
$654.33M
Business
QIAGEN N.V. is a foreign private issuer in Biological Products, (No Diagnostic Substances), headquartered in the Netherlands. Shares trade on NYSE under the ticker QGEN.
Auto-generated from company profile
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | $2.09B |
| Net income | $424.88M |
| Total assets | $6.28B |
| Total liabilities | — |
| Stockholders' equity | $3.78B |
| Operating cash flow | $654.33M |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Frequently asked questions
What is QIAGEN N.V.'s CIK number?
QIAGEN N.V.'s SEC CIK number is 0001015820 (1015820). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find QIAGEN N.V.'s SEC filings?
All of QIAGEN N.V.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.